Single-incision versus multiport video-assisted thoracoscopic surgery in the treatment of lung cancer: a systematic review and meta-analysis

Yang Zhang(Soochow University), Yunchao Huang(North China University of Water Resources and Electric Power), Qinghua Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhenghai Shen(Kunming Medical University)
Figshare
January 1, 2018
10.6084/m9.figshare.5432638
Cited by 0

Related Papers

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508
Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: Overall design and results from a multicenter retrospective epidemiologic survey
|Lung Cancer|2018|134
<scp>C</scp>hina national lung cancer screening guideline with low‐dose computed tomography (2015 version)
|Thoracic Cancer|2015|89
LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) versus gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFR M+) advanced adenocarcinoma of the lung.
|Journal of Clinical Oncology|2013|83